Introduction to Athersys Preclinical Programs
Let's dive into the details surrounding Athersys Preclinical Programs. Dr. Sarah Busch gives an overview of the exciting
Athersys Preclinical Programs Comprehensive Overview
Athersys Athersys Robert Mays, Ph.D., VP of Regenerative Medicine and Head of Neuroscience Cleveland, OH (NASDAQ:
Dr. Eric Jenkins, Senior Medical Director and Head of Clinical
Summary & Highlights for Athersys Preclinical Programs
- ATHERSYS
- ... Nonclinical Development, will be hosting a webinar to provide a comprehensive update on the Company's
- Presented by: Gil Van Bokkelen, Ph.D., Chairman & CEO
- Clip courtesy of Fox32 in Chicago.
- Trauma is the leading cause of death in people aged 1 to 44 and the leading cause of life years lost.
That wraps up our extensive overview of Athersys Preclinical Programs.
